Lactose (India) Ltd. Share Price & Stock Analysis

Lactose (India) Ltd. (BSE: 524202) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹132 Cr, it ranks #3,005 by market cap among the 6,197 Indian listed companies on FinBizNet, and #64 of 86 in Medicinal Chemicals and Botanical Products. At ₹106.00 (as of 16 Nov 2026), the share price is 22.3% below its 52-week high of ₹136.45 and 39.5% above its 52-week low of ₹76.01. The share price is down 7.8% over one year and down 1.1% over three months.

Key Metrics

Current Price₹106.00
Market Cap₹132 Cr
BSE Code524202
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio22.2
Return on Equity9.82%
Return on Assets5.00%
52-Week Range₹76.01 – ₹136.45
1-Year Price Change-7.8%
3-Month Price Change-1.1%
Beta (1Y)0.26
HeadquartersMumbai, Maharashtra
Websitewww.lactoseindialimited.com

Shareholding and Delivery

Delivery averaged 78.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Lactose (India) Ltd.

Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic. In addition, the company exports its products. Lactose (India) Limited was incorporated in 1991 and is headquartered in Mumbai, India.

Products and Services

1. Pharmaceuticals-This segment manufactures and trades in pharmaceutical products. 2. Segment Adjustment-This segment offers textile products. 3. Project Export-0 4. Textile-0

Business Segments

1. Manufacturing & Trading of Pharmaceutical Products-100%

Lactose (India) Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Lactose (India) Ltd.₹132 Cr22.29.82%—-7.8%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Lactose (India) Ltd.?

Lactose (India) Ltd. is trading at ₹106.00, with a market capitalisation of ₹132 Cr.

Which sector does Lactose (India) Ltd. belong to?

Lactose (India) Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Lactose (India) Ltd.?

Lactose (India) Ltd. has a P/E of 22.2 and a return on equity of 9.82%.

What is the stock symbol of Lactose (India) Ltd.?

Lactose (India) Ltd. is listed on the BSE under the scrip code 524202.

How has Lactose (India) Ltd.'s share price moved over the past year?

Lactose (India) Ltd.'s share price is down 7.8% over one year and down 1.1% over three months. Its 52-week range is ₹76.01 to ₹136.45.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.